DCGI grants conditional market approval for Covishield, Covaxin; may cost Rs 275 per dose

New Delhi/Bhubaneswar: The Drugs Controller General of India (DCGI) on Thursday granted the conditional market approval for Indian coronavirus vaccines Covishield and Covaxin.

The Serum Institute of India's Covishield and Bharat Biotech's Covaxin now have regular market nod and according to some reports, the vaccines may cost Rs 275 per dose.

More details to follow.